We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DASH:NASDAQDoorDash, Inc. Analysis

Data as of 2026-05-19 - not real-time

$155.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DoorDash (DASH) trades at $155.9, notably below its DCF‑derived fair value of roughly $192, delivering an implied upside of over 50%. The stock carries a trailing P/E near 74 but a forward P/E of about 20, reflecting strong earnings acceleration expectations (forward EPS $7.78 vs trailing $2.11) and a 33% year‑over‑year revenue growth rate. Margins remain modest (gross ~52%, operating ~5%) while cash on hand exceeds $5.5 bn, comfortably covering its $3.3 bn debt load. Technicals show a neutral price trend with the 20‑day SMA (~$166) just above current price, a bearish MACD histogram, and an RSI around 43, suggesting limited short‑term momentum. Volume is increasing, supporting liquidity. Recent material news highlighted a Q1 earnings beat and a stronger‑than‑expected Marketplace Gross Order Value outlook, reinforcing analyst consensus “Buy” and a median price target near $250.
Given the valuation gap, solid cash generation, and growth‑oriented outlook, the investment case leans toward a long‑run upside, though short‑term price pressure near the $148 support and elevated volatility (≈53% 30‑day) temper immediate conviction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the $148 support level
  • Bearish MACD histogram indicating limited upside momentum
  • Increasing volume providing a cushion against abrupt drops

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >50% upside
  • Forward earnings growth driving a forward P/E near 20
  • Analyst consensus “Buy” with median target around $250

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue growth (~33% YoY) and expanding marketplace footprint
  • Strong cash position relative to debt, supporting strategic investments
  • Market‑share gains and resilient business model despite macro headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth33.10%
Profit Margin6.29%
P/E Ratio73.9
ROE9.92%
ROA3.31%
Debt/Equity32.19
P/B Ratio6.7
Op. Cash Flow$2.4B
Free Cash Flow$2.3B

Technical Analysis

TrendNeutral
RSI42.6
Support$148.00
Resistance$184.17
MA 20$166.54
MA 50$164.01
MA 200$212.12
MACDBearish
VolumeIncreasing
Fear & Greed Index89.52

Valuation

Fair Value$191.98
Target Price$245.99
Upside/Downside57.82%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.27
Volatility53.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.